{"version":"1.0","provider_name":"Avalere Health Advisory","provider_url":"https:\/\/advisory.avalerehealth.com","title":"Therapeutic Vaccines Raise Regulatory, Policy Pathway Questions | Avalere Health Advisory","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"75SZS01D0P\"><a href=\"https:\/\/advisory.avalerehealth.com\/insights\/therapeutic-vaccines-raise-regulatory-policy-pathway-questions\">Therapeutic Vaccines Raise Regulatory, Policy Pathway Questions<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/advisory.avalerehealth.com\/insights\/therapeutic-vaccines-raise-regulatory-policy-pathway-questions\/embed#?secret=75SZS01D0P\" width=\"600\" height=\"338\" title=\"&#8220;Therapeutic Vaccines Raise Regulatory, Policy Pathway Questions&#8221; &#8212; Avalere Health Advisory\" data-secret=\"75SZS01D0P\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2023\/06\/22357-1-Haley_Payne-400x600-1.jpg","thumbnail_width":600,"thumbnail_height":400,"description":"[vc_row][vc_column][vc_column_text]Vaccines are conventionally administered prophylactically to prevent disease and associated morbidities. In recent years, manufacturers have increasingly used vaccine platform technology to develop therapeutic applications that treat or prevent disease exacerbation rather than prevent onset. In response to pipeline therapeutic vaccine progress toward late-stage development, policymakers are beginning to define policy and access pathways for&hellip;"}